BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20534349)

  • 1. The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility.
    Sagan SM; Nasheri N; Luebbert C; Pezacki JP
    Chem Biol; 2010 May; 17(5):515-27. PubMed ID: 20534349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and screening of siRNAs against highly structured RNA targets.
    Nasheri N; Pezacki JP; Sagan SM
    Methods Mol Biol; 2013; 942():69-86. PubMed ID: 23027046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfering with hepatitis C virus RNA replication.
    Randall G; Rice CM
    Virus Res; 2004 Jun; 102(1):19-25. PubMed ID: 15068876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
    Smith RM; Smolic R; Volarevic M; Wu GY
    J Viral Hepat; 2007 Mar; 14(3):194-212. PubMed ID: 17305886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs.
    Chang B; Lee CH; Lee JH; Lee SW
    Biotechnol Lett; 2010 Sep; 32(9):1231-7. PubMed ID: 20464448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA.
    Chang KS; Luo G
    Virus Res; 2006 Jan; 115(1):1-8. PubMed ID: 16102869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes.
    Khaliq S; Jahan S; Ijaz B; Ahmad W; Asad S; Hassan S
    Arch Virol; 2011 Mar; 156(3):433-42. PubMed ID: 21161551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of RNAi in the treatment of HCV infection.
    Volarevic M; Smolic R; Wu CH; Wu GY
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):823-31. PubMed ID: 17914916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
    Paek KY; Kim CS; Park SM; Kim JH; Jang SK
    J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siVirus: web-based antiviral siRNA design software for highly divergent viral sequences.
    Naito Y; Ui-Tei K; Nishikawa T; Takebe Y; Saigo K
    Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W448-50. PubMed ID: 16845046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV core protein interacts with Dicer to antagonize RNA silencing.
    Chen W; Zhang Z; Chen J; Zhang J; Zhang J; Wu Y; Huang Y; Cai X; Huang A
    Virus Res; 2008 May; 133(2):250-8. PubMed ID: 18325616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability and diversity of intracellular genome-length hepatitis C virus RNA in long-term cell culture.
    Kato N; Abe K; Mori K; Ariumi Y; Dansako H; Ikeda M
    Arch Virol; 2009; 154(1):77-85. PubMed ID: 19082684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.
    ElHefnawi M; Kim T; Kamar MA; Min S; Hassan NM; El-Ahwany E; Kim H; Zada S; Amer M; Windisch MP
    PLoS One; 2016; 11(7):e0159211. PubMed ID: 27441640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human metapneumovirus replication by small interfering RNA.
    Deffrasnes C; Cavanagh MH; Goyette N; Cui K; Ge Q; Seth S; Templin MV; Quay SC; Johnson PH; Boivin G
    Antivir Ther; 2008; 13(6):821-32. PubMed ID: 18839783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression.
    Suzuki H; Tamai N; Habu Y; Chang MO; Takaku H
    FEBS Lett; 2008 Sep; 582(20):3085-9. PubMed ID: 18692048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA.
    Chung RT; Kaplan LM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):351-62. PubMed ID: 9918842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.